3026790-19-9
Chemical Structure
Galeflaprit fumarate
Synonym(s): LXE408 fumarate
- CAS No.: 3026790-19-9
- Formula:C27H22FN7O6
- Molecular Weight:559.51
IUPAC Name: N-(4-fluoro-3-(6-(3-methylpyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)phenyl)-2,4-dimethyloxazole-5-carboxamide fumarate
InChIKey: FABLYHJOBQZOPC-WLHGVMLRSA-N
SMILES: O=C(C1=C(C)N=C(C)O1)NC2=CC=C(F)C(C3=NN4C=C(C5=NC=CC=C5C)C=NC4=N3)=C2.O=C(O)/C=C/C(O)=O
Biological Activity: Galeflaprit (LXE408) fumarate is an orally active, non-competitive and kinetoplastid-selective proteasome inhibitor.Galeflaprit fumarate has an IC50 of 0.04 μM for L. donovani proteasome and an EC50 of 0.04 μM for L. donovani. Galeflaprit fumarate has a low propensity to cross the blood brain barrier. Galeflaprit fumarate has the potential for visceral leishmaniasis (VL) research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Galeflaprit fumarate | Galeflaprit (LXE408) fumarate is an orally active, non-competitive and kinetoplastid-selective proteasome inhibitor.Galeflaprit fumarate has an IC50 of 0.04 μM for L. donovani proteasome and an EC50 of 0.04 μM for L. donovani. Galeflaprit fumarate has a low propensity to cross the blood brain barrier. Galeflaprit fumarate has the potential for visceral leishmaniasis (VL) research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
